Terms: = Prostate cancer AND SPOP, TEF2, 8405, ENSG00000121067, O43791
192 results:
1. Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.
Wan L; Fan Y; Wu T; Liu Y; Zhang R; Chen S; Zhao C; Xue Y
Eur J Med Res; 2024 Apr; 29(1):242. PubMed ID: 38643190
[TBL] [Abstract] [Full Text] [Related]
2. ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.
Lee CJ; Lee H; Kim SR; Nam SB; Lee GE; Yang KE; Lee GJ; Chun SH; Kang HC; Lee JY; Lee HS; Cho SJ; Cho YY
Cell Death Dis; 2024 Apr; 15(4):274. PubMed ID: 38632244
[TBL] [Abstract] [Full Text] [Related]
3. Deficiency in spop-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression.
Liu F; Zhang T; Sun X; Liu Z; Xu W; Dai X; Zhang X
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167032. PubMed ID: 38246227
[TBL] [Abstract] [Full Text] [Related]
4. Differences and Common Ground in
Farolfi A; Armstrong WR; Djaileb L; Gafita A; Hotta M; Allen-Auerbach M; Unterrainer LM; Fendler WP; Rettig M; Eiber M; Hofman MS; Hadaschik B; Herrmann K; Czernin J; Calais J; Benz MR
J Nucl Med; 2024 Mar; 65(3):438-445. PubMed ID: 38238041
[No Abstract] [Full Text] [Related]
5. LRP5 competes for spop binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer.
Gan S; Qu F; Zhang X; Pan X; Xu D; Cui X; Hou J
Exp Cell Res; 2024 Jan; 434(1):113857. PubMed ID: 38008278
[TBL] [Abstract] [Full Text] [Related]
6. Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via spop/ERα axis.
Ge Y; Jin J; Chen G; Li J; Ye M; Jin X
Cell Commun Signal; 2023 Oct; 21(1):303. PubMed ID: 37904149
[TBL] [Abstract] [Full Text] [Related]
7. Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.
Al-Toubat M; Serrano S; Elshafei A; Koul K; Feibus AH; Balaji KC
Urol Oncol; 2023 Nov; 41(11):455.e7-455.e15. PubMed ID: 37838503
[TBL] [Abstract] [Full Text] [Related]
8. The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (spop) and Androgen Receptor (AR) in a Single-Center pT3 prostatectomy Cohort.
Eryilmaz IE; Vuruskan BA; Kaygisiz O; Cecener G; Egeli U; Vuruskan H
J Environ Pathol Toxicol Oncol; 2024; 43(1):15-29. PubMed ID: 37824367
[TBL] [Abstract] [Full Text] [Related]
9. Opposing Roles of
Cavalcante L; Deshmukh SK; Ribeiro JR; Carneiro BA; Dizon DS; Angara K; Mattox T; Wu S; Xiu J; Walker P; Oberley M; Nabhan C; Huang H; Antonarakis ES
JCO Precis Oncol; 2023 Sep; 7():e2300088. PubMed ID: 37677121
[TBL] [Abstract] [Full Text] [Related]
10. Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.
Sumiyoshi T; Wang X; Warner EW; Sboner A; Annala M; Sigouros M; Beja K; Mizuno K; Ku S; Fazli L; Eastham J; Taplin ME; Simko J; Halabi S; Morris MJ; Gleave ME; Wyatt AW; Beltran H
J Natl Cancer Inst; 2024 Jan; 116(1):115-126. PubMed ID: 37676819
[TBL] [Abstract] [Full Text] [Related]
11. Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced prostate cancer Cell Migration and Cell Cycle Dysregulation, In Vitro.
Choudhry M; Gamallat Y; Ghosh S; Bismar TA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629142
[TBL] [Abstract] [Full Text] [Related]
12. spop Mutations Target STING1 Signaling in prostate cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.
Geng C; Zhang MC; Manyam GC; Vykoukal JV; Fahrmann JF; Peng S; Wu C; Park S; Kondraganti S; Wang D; Robinson BD; Loda M; Barbieri CE; Yap TA; Corn PG; Hanash S; Broom BM; Pilié PG; Thompson TC
Clin Cancer Res; 2023 Nov; 29(21):4464-4478. PubMed ID: 37581614
[TBL] [Abstract] [Full Text] [Related]
13. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Lang B; Cao C; Zhao X; Wang Y; Cao Y; Zhou X; Zhao T; Wang Y; Liu T; Liang W; Hu Z; Tian X; Zhang J; Yan Y
Eur J Med Res; 2023 Jul; 28(1):239. PubMed ID: 37461056
[TBL] [Abstract] [Full Text] [Related]
14. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
[TBL] [Abstract] [Full Text] [Related]
15. Somatic and Germline Variants Affect Prognosis and Susceptibility in prostate cancer.
Rocca C; Rocca G; Zampieri P; Dell'atti L; Bianchi N; Ippolito C; Aguiari G
Anticancer Res; 2023 Jul; 43(7):2941-2949. PubMed ID: 37351993
[TBL] [Abstract] [Full Text] [Related]
16. Genetic Profiling of African American Patients With Prostatic Adenocarcinoma Metastatic to the Lymph Nodes: A Pilot Study.
Bidot S; Yin J; Zhou P; Zhang L; Deeb KK; Smith G; Hill CE; Xiu J; Bilen MA; Case KB; Tinsley M; Carthon B; Harik LR
Arch Pathol Lab Med; 2024 Mar; 148(3):310-317. PubMed ID: 37327205
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Values of Gene Copy Number Alterations in prostate cancer.
Alfahed A; Ebili HO; Almoammar NE; Alasiri G; AlKhamees OA; Aldali JA; Al Othaim A; Hakami ZH; Abdulwahed AM; Waggiallah HA
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239316
[TBL] [Abstract] [Full Text] [Related]
18. TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks.
Ma J; Zhou Y; Pan P; Yu H; Wang Z; Li LL; Wang B; Yan Y; Pan Y; Ye Q; Liu T; Feng X; Xu S; Wang K; Wang X; Jian Y; Ma B; Fan Y; Gao Y; Huang H; Li L
Nat Commun; 2023 Mar; 14(1):1810. PubMed ID: 37002234
[TBL] [Abstract] [Full Text] [Related]
19. Glycyl-tRNA Synthetase (GARS) Expression Is Associated with prostate cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.
Khosh Kish E; Gamallat Y; Choudhry M; Ghosh S; Seyedi S; Bismar TA
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901698
[TBL] [Abstract] [Full Text] [Related]
20. spop is essential for DNA replication licensing through maintaining translation of CDT1 and CDC6 in HaCaT cells.
Sanada S; Maekawa M; Tate S; Nakaoka H; Fujisawa Y; Sayama K; Higashiyama S
Biochem Biophys Res Commun; 2023 Apr; 651():30-38. PubMed ID: 36791496
[TBL] [Abstract] [Full Text] [Related]
[Next]
